Symphony Holdings Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Los beneficios de Symphony Holdings han disminuido a una tasa media anual de -45%, mientras que en la industria Specialty Retail los beneficios disminuyeron en un 0.9% anualmente. Los ingresos han ido disminuyendo a una tasa media de 6.1% al año.

Información clave

-45.0%

Tasa de crecimiento de los beneficios

-45.1%

Tasa de crecimiento del BPA

Crecimiento de la industria Specialty Retail	1.1%
Tasa de crecimiento de los ingresos	-6.1%
Rentabilidad financiera	-8.4%
Margen neto	-67.6%
Última actualización de beneficios	31 Dec 2023

Actualizaciones de resultados anteriores recientes

Recent updates

Is Symphony Holdings (HKG:1223) Using Too Much Debt?

May 20

How Many Symphony Holdings Limited (HKG:1223) Shares Did Insiders Buy, In The Last Year?

Feb 18

Introducing Symphony Holdings (HKG:1223), A Stock That Climbed 16% In The Last Five Years

Jan 14

A Look At Symphony Holdings' (HKG:1223) CEO Remuneration

Dec 10

Is Symphony Holdings Limited (HKG:1223) Popular Amongst Insiders?

Nov 19

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Symphony Holdings. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

SEHK:1223 Ingresos, gastos y beneficios (HKD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
31 Dec 23	305	-206	226
30 Sep 23	301	-186	225
30 Jun 23	297	-166	223
31 Mar 23	288	-126	227
31 Dec 22	279	-85	231
30 Sep 22	299	-30	234
30 Jun 22	320	26	237
31 Mar 22	322	26	223
31 Dec 21	323	27	210
30 Sep 21	346	-15	213
30 Jun 21	369	-56	216
31 Mar 21	361	-136	217
31 Dec 20	352	-216	218
30 Sep 20	335	-175	223
30 Jun 20	317	-134	229
31 Mar 20	353	-31	237
31 Dec 19	389	72	244
30 Sep 19	388	97	245
30 Jun 19	388	123	245
31 Mar 19	385	121	268
31 Dec 18	382	118	291
30 Sep 18	380	78	299
30 Jun 18	378	38	308
31 Mar 18	364	40	295
31 Dec 17	349	41	282
30 Sep 17	348	52	272
30 Jun 17	347	62	261
31 Mar 17	355	45	250
31 Dec 16	364	28	239
30 Sep 16	363	22	243
30 Jun 16	361	16	247
31 Mar 16	356	98	273
31 Dec 15	351	181	299
30 Sep 15	336	179	304
30 Jun 15	324	178	310
31 Mar 15	294	84	293
31 Dec 14	264	-10	275
30 Sep 14	244	-63	277
30 Jun 14	233	-116	279
31 Mar 14	226	-139	276
31 Dec 13	219	-161	273
30 Sep 13	188	-151	261
30 Jun 13	164	-140	248

Ingresos de calidad: 1223 actualmente no es rentable.

Margen de beneficios creciente: 1223 actualmente no es rentable.

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: 1223 no es rentable, y las pérdidas han aumentado en los últimos 5 años a un ritmo de 45% al año.

Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de 1223 en el último año con su promedio de 5 años, ya que actualmente no es rentable.

Beneficios vs. Industria: 1223 no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Specialty Retail (-1.3%).

Rentabilidad financiera

Alta ROE: 1223 tiene una rentabilidad financiera negativa (-8.43%), ya que actualmente no es rentable.

Symphony Holdings Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Información clave

Actualizaciones de resultados anteriores recientes

Full year 2023 earnings released: HK$0.069 loss per share (vs HK$0.029 loss in FY 2022)

Symphony Holdings Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

First half 2023 earnings released: HK$0.029 loss per share (vs HK$0.002 loss in 1H 2022)

Full year 2022 earnings released: HK$0.029 loss per share (vs HK$0.012 profit in FY 2021)

First half 2022 earnings released: HK$0.002 loss per share (vs HK$0.002 loss in 1H 2021)

First half 2022 earnings released: HK$0.002 loss per share (vs HK$0.001 profit in 1H 2021)

Recent updates

Symphony Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2023

Full year 2023 earnings released: HK$0.069 loss per share (vs HK$0.029 loss in FY 2022)

Symphony Holdings Limited, Annual General Meeting, Jun 28, 2024

Symphony Holdings Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

Chairman & CEO recently bought HK$858k worth of stock

Symphony Holdings Limited (SEHK:1223) entered into share sale and purchase agreement to acquire additional 25% stake in SYM ITO Sales & Distribution Company Limited from ITOCHU Textile Prominent (Asia) Limited for HKD 7.8 million.

Chairman & CEO recently bought HK$2.8m worth of stock

Chairman & CEO recently bought HK$2.7m worth of stock

First half 2023 earnings released: HK$0.029 loss per share (vs HK$0.002 loss in 1H 2022)

COO & Executive Director recently bought HK$261k worth of stock

Symphony Holdings Limited Approves Final Dividend for the Year Ended 31 December 2022

Full year 2022 earnings released: HK$0.029 loss per share (vs HK$0.012 profit in FY 2021)

Chairman & CEO recently bought HK$170k worth of stock

Insufficient new directors

First half 2022 earnings released: HK$0.002 loss per share (vs HK$0.002 loss in 1H 2021)

Chairman & CEO recently bought HK$21m worth of stock

First half 2022 earnings released: HK$0.002 loss per share (vs HK$0.001 profit in 1H 2021)

Symphony Holdings Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 June 2022

Symphony Holdings Limited to Report First Half, 2022 Results on Aug 31, 2022

Yeung King Hang Resigns as Company Secretary of Symphony Holdings Limited

Symphony Holdings Limited Approves Final Dividend for the Year Ended 31 December 2021

Insufficient new directors

Full year 2021 earnings released: EPS: HK$0.012 (vs HK$0.073 loss in FY 2020)

Insufficient new directors

Chairman & CEO recently bought HK$1.2m worth of stock

First half 2021 earnings released: EPS HK$0.001 (vs HK$0.056 loss in 1H 2020)

Shunten International (Holdings) Limited (SEHK:932) completed the acquisition of 43.1% stake in Supremium Bio-Technology Limited from Symphony Holdings Limited (SEHK:1223).

First half 2021 earnings released: EPS HK$0.001 (vs HK$0.056 loss in 1H 2020)

Symphony Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended June 30, 2021

Shunten International (Holdings) Limited (SEHK:932) signed an agreement to acquire 43.1% stake in Supremium Bio-Technology Limited from Symphony Holdings Limited (SEHK:1223) for HKD 74.9 million.

Is Symphony Holdings (HKG:1223) Using Too Much Debt?

Chairman & CEO recently bought HK$2.5m worth of stock

Full year 2020 earnings released: HK$0.073 loss per share (vs HK$0.024 profit in FY 2019)

Symphony Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2020

Chairman & CEO recently bought HK$2.5m worth of stock

Full year 2020 earnings released: HK$0.073 loss per share (vs HK$0.024 profit in FY 2019)

Symphony Holdings Limited to Report Fiscal Year 2020 Results on Mar 26, 2021

How Many Symphony Holdings Limited (HKG:1223) Shares Did Insiders Buy, In The Last Year?

New 90-day high: HK$0.93

Chairman & CEO recently bought HK$1.7m worth of stock

Introducing Symphony Holdings (HKG:1223), A Stock That Climbed 16% In The Last Five Years

Chairman & CEO recently bought HK$1.2m worth of stock

New 90-day low: HK$0.84

A Look At Symphony Holdings' (HKG:1223) CEO Remuneration

Symphony Holdings Limited and ITOCHU Corporation and its Subsidiary Entered into a Joint Venture Agreement

Is Symphony Holdings Limited (HKG:1223) Popular Amongst Insiders?

Insider recently sold HK$28m worth of stock

New 90-day high: HK$0.95

First half earnings released

New 90-day high: HK$0.91

First half earnings released

Symphony Holdings Limited to Report First Half, 2020 Results on Aug 31, 2020

New 90-day low - HK$0.85

Desglose de ingresos y gastosBeta

Historial de beneficios e ingresos

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Rentabilidad financiera

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado

Desglose de ingresos y gastos
Beta